SAN FRANCISCO–(BUSINESS WIRE)–Savonix,
a global leader in digital tests for cognitive health, announced today
that the Company will be presenting at the upcoming conferences:
International
Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019
Dr. Mylea Charvat, CEO and Founder of Savonix will be speaking at the
following conferences:
Global
CEO Initiative on Alzheimer’s Disease (CEOi) and Ministry of
Economy, Trade and Industry of Japan (METI) Roundtable Discussion on
Brain Health
Global
Insurtech Leaders Summit
GENTRY
Women in Tech Conference 2019
Geodesic
Capital Annual Meeting (closed to press)
About Savonix
Savonix delivers a fully mobile assessment of cognitive function
available on Android and iOS for phone and tablet, the Savonix Cognitive
Assessment platform is an accurate, accessible and affordable tool for
professional cognitive screens. It empowers healthcare providers, payers
and researchers to evaluate and leverage results to improve health and
treatment outcomes. Led by clinical neuropsychologists and digital
health technology experts, the company has established itself as an
authority on cognition globally. To learn more about Savonix, visit Savonix.com.
Contacts
Savonix
Kimberly Ha
KKH Advisors
kimberly.ha@kkhadvisors.com
917-291-5744
Reduces Waystar's cost of capital and enhances its ability to allocate free cash flow towards…
HOUSTON, June 27, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:…
License provides exclusive access to innovative epigenetic editors and expands the reach of Chroma's platform…
Nationwide Walk Series Kicks Off July 20 in Pittsburgh CHICAGO, June 27, 2024 /PRNewswire/ --…
This unique, proprietary service is exclusively available to Magnolia Medical customers as part of its…
The Venture Capital Firm Set to Expand Investments in Innovative Healthcare Companies NEW YORK, June…